Physician profile
Alice Chen
NPI 1841491685
$5,184.25
in general payments reported to CMS, 2019-2025
22 companies · $270 in 2025
The $270 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $879 · 2020: $409 · 2021: $2,372 · 2022: $387 · 2023: $352 · 2024: $515 · 2025: $270.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,138.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,137.71 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Gilead Sciences, INC. | $2,478.88 | 2019-2025 | Vemlidy |
| Novo Nordisk INC | $593.88 | 2020-2025 | Ozempic, Rybelsus |
| Astrazeneca Pharmaceuticals LP | $518.22 | 2019-2025 | Airsupra, Breztri, Farxiga |
| Boehringer Ingelheim Pharmaceuticals, INC. | $232.87 | 2020-2025 | Jardiance, Synjardy |
| Amarin Pharma, INC. | $178.94 | 2019-2022 | |
| Amgen INC. | $166.21 | 2021-2025 | Evenity, Prolia, Otezla |
| Glaxosmithkline, LLC. | $161.28 | 2024 | Arexvy, Trelegy Ellipta |
| Merck Sharp & Dohme LLC | $124.12 | 2019-2021 | |
| Eisai INC. | $114.83 | 2019 | |
| Pfizer INC. | $104.85 | 2021-2025 | |
| Lilly USA, LLC | $101.08 | 2020-2024 | Mounjaro, Trulicity, Jardiance |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $99.07 | 2019 | |
| Sanofi-Aventis U.S. LLC | $56.44 | 2020-2021 | |
| Dexcom, INC. | $47.25 | 2024-2025 | Dexcom G6 Transmitter |
| Dynavax Technologies Corporation | $45.13 | 2019 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Exact Sciences Corporation | $43.25 | 2023-2025 | Cologuard Collection Kit |
| Kowa Pharmaceuticals America, INC. | $28.01 | 2019-2023 | Livalo |
| Vbi Vaccine (Delaware) INC. | $26.27 | 2023 | Prehevbrio |
| Agios Pharmaceuticals, INC. | $22.73 | 2025 | Pyrukynd |
| Bayer Healthcare Pharmaceuticals INC. | $17.63 | 2023 | |
| Medtronic Vascular, INC. | $12.48 | 2020 | |
| Arbor Pharmaceuticals, INC. | $10.83 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alice Chen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.